semaglutide and masld Semaglutide's Efficacy in Phase 3 MASH Trial Which patients should clinicians screen

The app starts with the 18 most common GLP-1 side effects, plus unlimited custom symptoms, including nausea, vomiting, constipation, diarrhea, fatigue, headache, and stomach pain

however, this medication is injected daily

& Volland, G

As a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist, it mimics the action of two natural incretin hormones your body produces after eating

Management includes optimising nutrition, maintaining hydration, gradual dose escalation, and monitoring for hypoglycaemia if using other glucose-lowering medications

Fabrini R, Bocedi A, Massoud R, Federici G, Ricci G